Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 4 randomized parallel trial of freeze-dried live hepatitis A vaccines in children 18-24 months old
ChiCTR2000039454Phase 4Recruiting
- Sponsor
- Shaanxi Provincial Center for Disease Control and Prevention
- Start
- Oct 2020
- Modality
- Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Hepatitis A virus vaccine in hepatitis A (HAV) (3 arms), sponsored by Shaanxi Provincial Center for Disease Control and Prevention. Primary endpoint: Antibody seroconversion rate. Started Oct 2020; status: recruiting.
02
Drugs
Hepatitis A virus vaccine
03
Conditions
hepatitis A (HAV)
Beyond the preview
Go deeper on ChiCTR2000039454.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000039454.